Selective immunotherapy of IDDM: a discussion based on new findings from the RIP-LCMV model for autoimmune diabetes.
von Herrath
M G
MG
Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037, USA.
D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000628:therapy*; D004195:Disease Models, Animal; D006801:Humans; D007167:Immunotherapy; D007328:Insulin / Q000235:genetics / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000276:immunology* / Q000378:metabolism; D008217:Lymphocytic choriomeningitis virus; D051379:Mice; D008822:Mice, Transgenic; D018448:Models, Immunological; D011401:Promoter Regions, Genetic; D051381:Rats
D007328:Insulin